Cigna (CI) Q3 2025 10-Q Quarterly Report

Filed: Oct 30, 2025Period ending Sep 30, 2025
Financials
Hospital & Medical Service PlansSEC EDGAR

Cigna (CI) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 30, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

Cigna Q3 2025 10-Q Analysis

Management Discussion & Analysis

  • No quarterly revenue or YoY change data provided in disclosed text
  • No profitability or margin figures included in provided section
  • No segment or product line performance metrics mentioned
  • No cash position, operating cash flow, or capital deployment details given
  • No management commentary on near-term outlook, guidance, or headwinds available

Risk Factors

  • Debt securities portfolio carrying value decreased from $9.4B to $8.4B due to HCSC transaction, unrealized depreciation from rising interest rates
  • Commercial mortgage loan portfolio $1.3B with <25% exposure to office properties amid weak sector fundamentals beginning to stabilize
  • Other long-term investments $4.9B, diversified with no single partnership >3% and <4% exposure to office real estate, expecting continued valuation volatility
  • Unconsolidated subsidiary joint venture in China holds $17.4B investment portfolio, no material unrealized losses as of September 30, 2025
  • Market risk exposure to interest rate risk unchanged from 2024 Form 10-K, no material change in risk profile reported

Cigna Q3 2025 Quarterly Financials
XBRL

Revenue

$69.7B

+9.5% YoY +3.8% QoQ

Net Income

$1.9B

+152.8% YoY +21.9% QoQ

Operating Margin

3.7%

-35bp YoY +26bp QoQ

Net Margin

2.7%

+152bp YoY +40bp QoQ

ROE

4.5%

Total Assets

$157.9B

EPS (Diluted)

$6.97

+166.0% YoY +22.3% QoQ

Operating Cash Flow

$3.4B

+7330.4% YoY +281.2% QoQ

Source: XBRL data from Cigna Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Cigna Quarterly Reports

Get deeper insights on Cigna

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.